Clinical Evidence

Respifor® is clinically proven in several trials in moderate and severe COPD patients. These trials were conducted in both the hospital and community setting and provide evidence for the benefits to patients of using Respifor® in combination with exercise in gaining muscle mass, increasing their physical performance, reducing exacerbations, and improving patients’ quality of life.

Click a title below to read the abstract